Down-regulation of Plasminogen Activator Inhibitor-1 (PAI-1) by in vivo Thrombin Generation and Subsequent Formation of Activated Protein C (APC) in Carriers of the Factor V Leiden (FVL) and Prothrombin 20210G>A Mutation (PTM) -
Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation | NEJM
IJMS | Free Full-Text | PAI-1, the Plasminogen System, and Skeletal Muscle
Frontiers | Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
The PAI‐1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women - SAID - 2012 - Journal of Thrombosis and Haemostasis - Wiley Online Library
Human Pai 1 Recombinant Stable Mutant – Innovative Research
Figure 1 from Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer. | Semantic Scholar
Final Diagnosis -- Case 883
PAI-1 contributes to homocysteine-induced cellular senescence - ScienceDirect
IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
Cancers | Free Full-Text | Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
Table 1 from Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. | Semantic Scholar
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
A scheme of the angotensin/®brinolysis pathway, illustrating the key... | Download Scientific Diagram
PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma | Journal of Clinical Pathology
Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting